The Moores Orthopaedic Clinic has got approval from the RCVS Ethics Review Panel to offer Biomedtrix third-generation TATE elbow replacement surgery for dogs with severe osteoarthritis as part of a clinical evaluation trial for the implant.

The original TATE elbow replacement was first in clinical use in the 2010s and the revised 3rd generation version is apparently a much-improved implant, something which the clinical evaluation trial should demonstrate.

Andy Moores, head of the joint replacement programme at The Moores Orthopaedic Clinic, said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.

"The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.

"We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this.

"We look forward to offering this surgery as an option for some of our most painful canine patients.”

www.mooresortho.com

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.